Contribution of Environmental Toxicants and Lifestyle in Development of Cardiovascular Diseases
Abstract
Environmental pollutants and lifestyle factors are significantly contribute to the development of cardiovascular diseases (CVD), which are the major cause of mortality and morbidity worldwide. Exposure of heavy metals such as lead, chromium and Arsenic particulate matter (PM 2.5 and PM 10), and persistent organic pollutants like dichloro diphenyl trichloroethane and dichlorodiphenyl dichloroethylene are critical factors affecting cardiovascular health and cause CVD. Evidence suggests that these pollutants and various lifestyle choices such as smoking, and physical inactivity, activates multiple pathways including oxidative stress, systemic inflammation, and endothelial dysfunction thereby increasing risk of CVD. This review aims to critically analyze the complex relationship between environmental contaminants and sedentary lifestyle and their involvement in CVD risk.
Editorial Note on Version of Record
03 Oct 2026: This article has been corrected. See https://doi.org/10.62940/als.v13i0.4382 for more information.
Full Text:
PDFReferences
Aryal N, Wood J, Rijal I, Deng D, Jha MK, Ofori-Boadu A. Fate of environmental pollutants: A review. Water Environmental Research, (2020); 92(10): 1587-1594.
Manisalidis I, Stavropoulou E, Stavropoulos A, Bezirtzoglou E. Environmental and Health Impacts of Air Pollution:A review. Frontiers in Public Health, (2020); 8: 14.
Gomes M, Ralph TJ, Humphries MS, Graves BP, Kobayashi T, Gore DB. Waterborne contaminants in high intensity agriculture and plant production: A review of on-site and downstream impacts. The Science of the Total Environment, (2025); 958: 178084.
Alengebawy A, Abdelkhalek ST, Qureshi SR, Wang MQ. Heavy Metals and Pesticides Toxicity in Agricultural Soil and Plants: Ecological Risks and Human Health Implications. Toxics, (2021); 9(3): 42.
Di Cesare M, Perel P, Taylor S, Kabudula C, Bixby H, Gaziano TA, et al. The Heart of the World. Global Heart, (2024); 19(1): 11.
Ghodeshwar GK, Dube A, Khobragade D. Impact of Lifestyle Modifications on Cardiovascular Health: A Narrative Review. Cureus, 2023;15(7): e42616.
Shrivastav A, Swetanshu, Singh P. The Impact of Environmental Toxins on Cardiovascular Diseases. Current Problems in Cardiology, 2024 Jan;49(1 Pt C):102120.
Global Cardiovascular Risk Consortium; Magnussen C, Ojeda FM, Leong DP, Alegre-Diaz J, Amouyel P, Aviles-Santa L, et al. . Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality. The New England Journal of Medicine, (2023); 389(14): 1273–1285.
Liang Y, et al. Association of heavy metals exposure with lower blood pressure in the population aged 8-17 years: a cross-sectional study based on NHANES. Frontiers in Public Health, (2024); 12:1411123.
Vrijheid M, Martinez D, Aguilera I, Ballester F, Basterrechea M, Esplugues A, et al. Socioeconomic status and exposure to multiple environmental pollutants during pregnancy: evidence for environmental inequity?. Journal of Epidemiology and Community Health, (2012); 66(2): 106–113.
Awe Y, Larsen B, Hoossein S, Sánchez-Triana E. The Global Health Cost of Ambient PM2.5 Air Pollution. World Bank, 2020.
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. British Medical Journal (Clinical Research Edition), (2021) 372, n71. https://doi.org/10.1136/bmj.n71
Kupcikova Z, Fecht D, Ramakrishnan R, Clark C, Cai YS. Road traffic noise and cardiovascular disease risk factors in UK Biobank. European Heart Journal, (2021); 42(21): 2072–2084.
Ni Y, Tracy RP, Cornell E, Kaufman JD, Szpiro AA, Campen MJ, et al. Short-term exposure to air pollution and biomarkers of cardiovascular effect: A repeated measures study. Environmental Pollution (Barking, Essex: 1987), (2021); 279: 116893.
Abohashem S, Osborne MT, Dar T, Naddaf N, Abbasi T, Ghoneem A, et al. A leucopoietic-arterial axis underlying the link between ambient air pollution and cardiovascular disease in humans. European Heart Journal, (2021); 42(7): 761–772.
Tripathy S, Marsland AL, Kinnee EJ, Tunno BJ, Manuck SB, Gianaros PJ, et al. Long-Term Ambient Air Pollution Exposures and Circulating and Stimulated Inflammatory Mediators in a Cohort of Midlife Adults. Environmental Health Perspectives, (2021); 129(5): 57007.
Mann, J. K., Lutzker, L., Holm, S. M., Margolis, H. G., Neophytou, A. M., Eisen, E. A., et al.. Traffic-related air pollution is associated with glucose dysregulation, blood pressure, and oxidative stress in children. Environmental research, (2021); 195, 110870.
Elbarbary, M., Oganesyan, A., Honda, T., Morgan, G., Guo, Y., Guo, Y., et al. Systemic Inflammation (C-Reactive Protein) in Older Chinese Adults Is Associated with Long-Term Exposure to Ambient Air Pollution. International journal of environmental research and public health, (2021); 18(6), 3258.
McGraw KE, Riggs DW, Rai S, Navas-Acien A, Xie Z, Lorkiewicz P, et al. Exposure to volatile organic compounds - acrolein, 1,3-butadiene, and crotonaldehyde - is associated with vascular dysfunction. Environmental Research, (2021); 196: 110903.
Nawsherwan, Mubarik, S., Bin, W., Le, Z., Sang, M., Lin, Y., et al. Epidemiological Trends in Cardiovascular Disease Mortality Attributable to Modifiable Risk Factors and Its Association with Sociodemographic Transitions across BRICS-Plus Countries. Nutrients, (2023); 15(17), 3757. https://doi.org/10.3390/nu15173757
Shetty, S. S., D, D., S, H., Sonkusare, S., Naik, P. B., Kumari N, S., et al. Environmental pollutants and their effects on human health. Heliyon, (2023); 9(9), e19496.
Miller M. R. The cardiovascular effects of air pollution: Prevention and reversal by pharmacological agents. Pharmacology & therapeutics, (2022); 232, 107996. https://doi.org/10.1016/j.pharmthera.2021.107996
Ji J. S. Air pollution and cardiovascular disease onset: hours, days, or years?. The Lancet. Public health, (2022); 7(11), e890–e891. https://doi.org/10.1016/S2468-2667(22)00257-2
Dockery DW, Pope CA 3rd, Xu X, Spengler JD, Ware JH, Fay ME, et al. An association between air pollution and mortality in six U.S. cities. The New England Journal of Medicine, (1993); 329(24): 1753–1759.
Han B, Zhao R, Zhang N, Xu J, Zhang L, Yang W, et al. Acute cardiovascular effects of traffic-related air pollution (TRAP) exposure in healthy adults: A randomized, blinded, crossover intervention study. Environmental Pollution (Barking, Essex: 1987), (2021); 288: 117583.
Hamanaka RB, Mutlu GM. Particulate matter air pollution: effects on the cardiovascular system. Frontiers in Endocrinology, (2018); 9:680.
Shkirkova K, Lamorie-Foote K, Connor M, Patel A, Barisano G, Baertsch H, Liu Q, Morgan TE, Sioutas C, Mack WJ. Effects of ambient particulate matter on vascular tissue: a review. Journal of Toxicology and Environmental Health, Part B, (2020); 23(7):319-350.
Xing YF, Xu YH, Shi MH, Lian YX. The impact of PM2.5 on the human respiratory system. Journal of Thoracic Disease, (2016); 8(1): E69–E74.
Pizzino G, Irrera N, Cucinotta M, Pallio G, Mannino F, Arcoraci V, et al. Oxidative Stress: Harms and Benefits for Human Health. Oxidative Medicine and Cellular Longevity, (2017); 2017: 8416763.
De NB, CataldiS E, Diquigiovanni C, Bonora E. Calcium and Reactive Oxygen Species Signaling Interplays in Cardiac Physiology and Pathologies. Antioxidants (Basel, Switzerland), (2023); 12(2): 353.
Sagheer U, Al-Kindi S, Abohashem S, Phillips CT, Rana JS, Bhatnagar A, et al. Environmental pollution and cardiovascular disease: Part 2 of 2: soil, water, and other forms of pollution. JACC Advances, (2024); 3(2): 100815.
Chowdhury R, Ramond A, O'Keeffe LM, Shahzad S, Kunutsor SK, Muka T, et al. Environmental toxic metal contaminants and risk of cardiovascular disease: systematic review and meta-analysis. BMJ, (2018); 362: k3310.
Fu Z, Xi S. The effects of heavy metals on human metabolism. Toxicology Mechanisms and Methods, (2020); 30(3): 167–176.
Khan K, Room SA, Bacha AU, Nabi I,et al. Assessment of heavy metals among auto workers in metropolitan city: a case study. Frontiers in Public Health, (2023); 11: 1277182.
Tchounwou PB, Yedjou CG, Patlolla AK, Sutton DJ. Heavy metal toxicity and the environment. Experientia Supplementum (2012), (2012); 101: 133–164.
Jaishankar M, Tseten T, Anbalagan N, Mathew BB, Beeregowda KN. Toxicity, mechanism and health effects of some heavy metals. Interdisciplinary Toxicology, (2014); 7(2): 60–72.
Ericson B, Dowling R, Dey S, Caravanos J, Mishra N,et al. A meta-analysis of blood lead levels in India and the attributable burden of disease. Environment International, (2018); 121(Pt 1): 461–470.
Singh AP, Goel RK, Kaur T. Mechanisms pertaining to arsenic toxicity. Toxicology International, (2011); 18(2): 87–93.
Charkiewicz AE, Omeljaniuk WJ, Nowak K, Garley M, Nikliński J. Cadmium Toxicity and Health Effects-A Brief Summary. Molecules (Basel, Switzerland), (2023); 28(18): 6620.
Sears CG, Eliot M, Raaschou-Nielsen O, Poulsen AH, Harrington JM, et al. Urinary Cadmium and Incident Heart Failure: A Case-Cohort Analysis Among Never-Smokers in Denmark. Epidemiology (Cambridge, Mass.), (2022); 33(2): 185–192.
Angeli JK, Cruz PCA, de OFT, Stefanon I, Padilha AS, Vassallo DV. Cadmium exposure induces vascular injury due to endothelial oxidative stress: the role of local angiotensin II and COX-2. Free Radical Biology & Medicine, (2013); 65: 838–848.
Olszowski T, Baranowska BI, Gutowska I, Chlubek D. Pro-inflammatory properties of cadmium. Acta Biochimica Polonica, (2012); 59(4): 475–482.
Vaziri ND. Mechanisms of lead-induced hypertension and cardiovascular disease. American Journal of Physiology. Heart and Circulatory Physiology, (2008); 295(2): H454–H465.
Navas-Acien A, Guallar E, Silbergeld EK, Rothenberg SJ. Lead exposure and cardiovascular disease--a systematic review. Environmental Health Perspectives, (2007); 115(3): 472-482.
States JC, Srivastava S, Chen Y, Barchowsky A. Arsenic and cardiovascular disease. Toxicological Sciences: An Official Journal of the Society of Toxicology, (2009); 107(2): 312–323.
Moon K, Guallar E, Navas-Acien A. Arsenic exposure and cardiovascular disease: an updated systematic review. Current Atherosclerosis Reports, (2012); 14(6): 542–555.
Pérez-CFM, Barrios RR, GómezPC, Salcedo BI, Velasco GME, Jiménez MJJ, et al. Public healthcare costs associated with long-term exposure to mixtures of persistent organic pollutants in two areas of Southern Spain: A longitudinal analysis. Environment International, (2021); 156: 106734.
Diamanti KE, Bourguignon JP, Giudice LC, Hauser R, Prins GS, et al. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocrine Reviews, (2009); 30(4): 293–342.
Schillemans T, Yan Y, Ribbenstedt A, DonatVC, Lindh CH, Kiviranta H,et al. OMICs Signatures Linking Persistent Organic Pollutants to Cardiovascular Disease in the Swedish Mammography Cohort. Environmental Science & Technology, (2024); 58(2): 1036–1047.
Schwartz, L., Guais, A., Chaumet-Riffaud, P., Grévillot, G., Sasco, A. J., Molina, T. J., & Mohammad, A. (2010). Carbon dioxide is largely responsible for the acute inflammatory effects of tobacco smoke. Inhalation toxicology, 22(7), 543–551. https://doi.org/10.3109/08958370903555909
Bonefeld-Jørgensen EC, Ghisari M, Wielsøe M, Bjerregaard-Olesen C, Kjeldsen LS, Long M. Biomonitoring and hormone-disrupting effect biomarkers of persistent organic pollutants in vitro and ex vivo. Basic & Clinical Pharmacology & Toxicology, (2014); 115(1): 118–128.
Lind PM, Lind L. Are Persistent Organic Pollutants Linked to Lipid Abnormalities, Atherosclerosis and Cardiovascular Disease? A Review. Journal of Lipid and Atherosclerosis, (2020); 9(3): 334–348.
Farhud DD. Impact of lifestyle on health. Iranian Journal of Public Health, (2015); 44(11): 1442–1444.
Kirwan JP, Sacks J, Nieuwoudt S. The essential role of exercise in the management of type 2 diabetes. Cleveland Clinic Journal of Medicine, (2017); 84(7 Suppl 1):S15-S21.
Zhu Y, Li Q, Jiang H. Gut microbiota in atherosclerosis: focus on trimethylamine N-oxide. APMIS: Acta Pathologica, Microbiologica, et Immunologica Scandinavica, (2020); 128(5):353-366.
Clemente SVJ, Beltrán VAI, Redondo FL, Martín RA, Tornero AJF. Global Impacts of Western Diet and Its Effects on Metabolism and Health: A Narrative Review. Nutrients, (2023); 15(12): 2749.
Lavie CJ, Ozemek C, Carbone S, Katzmarzyk PT, Blair SN. Sedentary Behavior, Exercise, and Cardiovascular Health. Circulation Research, (2019); 124(5): 799–815.
Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature, (2011); 472(7341): 57-63.
Geng J, Yang C, Wang B, Zhang X, Hu T, Gu Y, Li J. Trimethylamine N-oxide promotes atherosclerosis via CD36-dependent MAPK/JNK pathway. Biomedicine & Pharmacotherapy, (2018); 97: 941-947.
Oktaviono YH, Dyah Lamara A, Saputra PBT, Arnindita JN, Pasahari D, Saputra ME, et al. The roles of trimethylamine-N-oxide in atherosclerosis and its potential therapeutic aspect: A literature review. Biomolecule Biomedicine. 2023; 3;23(6):936-948.
Masenga SK, Hamooya B, Hangoma J, Hayumbu V, Ertuglu LA, Ishimwe J, et al. Recent advances in modulation of cardiovascular diseases by the gut microbiota. Journal of Human Hypertension, (2022); 36(9): 952–959.
Nesci A, Carnuccio C, Ruggieri V, D'Alessandro A, Di Giorgio A, Santoro L,et al. Gut Microbiota and Cardiovascular Disease: Evidence on the Metabolic and Inflammatory Background of a Complex Relationship. International Journal of Molecular Sciences, (2023); 24(10): 9087.
Singh P, Meenatchi R, Ahmed ZHT, Thacharodi A, Rohinth M, Kumar RRS, et al. Implications of the gut microbiome in cardiovascular diseases: Association of gut microbiome with cardiovascular diseases, therapeutic interventions and multi-omics approach for precision medicine. Medicine in Microecology, (2024); 19: 100096.
Bhatnagar A. Environmental determinants of cardiovascular disease. Circulation Research, (2017); 121(2): 162–180.
Sharifi RJ, Rodrigues CF, Sharopov F, Docea AO, Can KA, Sharifi R M,et al. Diet, Lifestyle and Cardiovascular Diseases: Linking Pathophysiology to Cardioprotective Effects of Natural Bioactive Compounds. International Journal of Environmental Research and Public Health, (2020); 17(7): 2326.
Yu E, Malik VS, Hu FB. Cardiovascular Disease Prevention by Diet Modification: JACC Health Promotion Series. Journal of the American College of Cardiology, (2018); 72(8): 914–926.
Lobo V, Patil A, Phatak A, Chandra N. Free radicals, antioxidants and functional foods: Impact on human health. Pharmacognosy Reviews, (2010); 4(8): 118–126.
Hadley MB, Baumgartner J, Vedanthan R. Developing a clinical approach to air pollution and cardiovascular health. Circulation, (2018); 137(7):725-742.
Nystoriak MA, Bhatnagar A. Cardiovascular Effects and Benefits of Exercise. Frontiers in Cardiovascular Medicine, (2018); 5: 135.
Pagan LU, Gomes MJ, Okoshi MP. Endothelial Function and Physical Exercise. Arquivos Brasileiros de Cardiologia, (2018); 111(4): 540–541.
Kullo IJ, Cooper LT. Early identification of cardiovascular risk using genomics and proteomics. Nature Reviews Cardiology, (2010); 7(6): 309-317.
Tahir UA, Gerszten RE. Omics and cardiometabolic disease risk prediction. Annual Review of Medicine, (2020); 71: 163-175.
Montano L, Pironti C, Pinto G, Ricciardi M, Buono A, Brogna, C, et al. Polychlorinated biphenyls (PCBs) in the environment: Occupational and exposure events, effects on human health and fertility. Toxics, (2022); 10(7): 365.
Kumar R, Verma A, Shome A, Sinha R, Sinha S, Jha PK, et al. Impacts of plastic pollution on ecosystem services, sustainable development goals, and need to focus on circular economy and policy interventions. Sustainability, (2021); 13(17): 9963.
Dhingra R, Vasan RS. Biomarkers in cardiovascular disease: Statistical assessment and section on key novel heart failure biomarkers. Trends in Cardiovascular Medicine, (2017); 27(2): 123–133.
Javaid A, Zghyer F, Kim C, Spaulding EM, Isakadze N, Ding J, et al. Medicine 2032: The future of cardiovascular disease prevention with machine learning and digital health technology. American Journal of Preventive Cardiology, (2022); 12: 100379.
Zhan C, Tang T, Wu E, Zhang Y, He M, Wu R, et al. From multi-omics approaches to personalized medicine in myocardial infarction. Frontiers in Cardiovascular Medicine, (2023); 10: 1250340.
de B RA, Heymans S, Backs J, Carrier L, Coats AJS, Dimmeler S, et al. Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC). European Journal of Heart Failure, (2022); 24(3): 406–420.
Barresi V, Musmeci C, Rinaldi A, Condorelli DF. Transcript-targeted therapy based on RNA interference and antisense oligonucleotides: Current applications and novel molecular targets. International Journal of Molecular Sciences, (2022); 23(16): 8875.
Afifa, Arshad K, Hussain N, Ashraf MH, Saleem MZ. Air pollution and climate change as grand challenges to sustainability. Science of the Total Environment, (2024); 928: 172370.
Kumar P, Upadhyay E, Kannan K, Yadav A. Evaluation of cooking practices in India to achieve SDGs 7.1.2. Physics and Chemistry of the Earth, (2024); 136: 103774.
Kumar R, Garg S, Kaur R, Johar MGM, Singh S, Menon SV, et al. comprehensive review of machine learning for heart disease prediction: challenges, trends, ethical considerations, and future directions. Frontiers in Artificial Intelligence, (2025); 8: 1583459.
Mathur P, Srivastava S, Xu X, Mehta JL. Artificial intelligence, machine learning, and cardiovascular disease. Clinical Medicine Insights: Cardiology, (2020); 14: 1–9.
Dabla PK, Upreti K, Shrivastav D, Mehta V, Singh D. Discovering hidden patterns: Association rules for cardiovascular diseases in type 2 diabetes mellitus. World Journal of Methodology, (2024); 14(2): 92608.
DOI: https://doi.org/10.62940/als.v12i4.3720
Refbacks
- There are currently no refbacks.